-
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com
Source: Buzz FX / 06 Feb 2025 04:21:09 America/New_York
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat February 6, 2025 Share Link copied to clipboard. StockNews.com initiated coverage on shares of Revance Therapeutics ( NASDAQ:RVNC - Ge
Read more...